Dilated cardiomyopathy due to anthracycline toxicity (Q106814): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
16 August 2026
| |||||||||||||||
| Property / Collection date: 16 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:48, 17 August 2026
Dilated cardiomyopathy due to the chronic use of anthracycline chemotherapy drugs, such as doxorubicin and daunorubicin.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_529797652 |
||
| English | Dilated cardiomyopathy due to anthracycline toxicity |
Dilated cardiomyopathy due to the chronic use of anthracycline chemotherapy drugs, such as doxorubicin and daunorubicin. |
Statements
CID11:ID_529797652
0 references
dki-india-ID_529797652
0 references
Concluído
0 references
16 August 2026
0 references
